- Investing Ideas
- Polish Pharmaceuticals & Biotech Top Stock Picks from Analysts
Polish Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
3
0 new
Companies which are more than 50% undervalued based on analyst price target.
3 companies
Ryvu Therapeutics
Market Cap: zł321.4m
A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.
RVU
zł13.76
7D
-3.5%
1Y
-57.5%
Poltreg
Market Cap: zł112.1m
A biotechnology company, researches and develops therapies for autoimmune diseases.
PTG
zł18.70
7D
2.5%
1Y
-42.5%
Molecure
Market Cap: zł112.1m
A biotechnology company, engages in discovering, developing, and commercializing therapeutics for neoplastic and inflammatory diseases in Poland.
MOC
zł5.50
7D
-1.8%
1Y
-0.9%